8-Oxa-2-azaspiro[4.5]decane hydrochloride, 97%, 25g

N-(2-(3-Oxa-1-azaspiro[4.5]dec-1-en-2-yl)phenyl)quinoline-2-carboxamide, 100mg

(R)-2-Methoxy-2-phenylacetic acid, 98.0%, 1g

Dodecyl 4-hydroxybenzoate, 95.0%, 25g

Na-Boc-Nb-Azido-D-2,3-diaminopropionic acid cyclohexylammonium salt, 99.0%, 5g

4-Chlorobenzo[c][1,2,5]thiadiazole, 95.0%, 5g

2-(tert-Butyl)-4,5-dichloropyridazin-3(2H)-one, 95.0%, 10g

5-(3-fluorophenyl)-4H-1,2,4-triazol-3-amine, 95.0%, 5g

4-chlorobenzene-1-sulfonamide, 95.0%, 10g

Noir brillant BN (CI 28440), pa, 100 g, emballage verre

(E)-3-(2-Methoxypyridin-3-yl)acrylic acid, 98%, 1g

N-butyl-N-methylpyrrolidinium bis((trifluoromethyl)sulfonyl)imide, 98.0%, 100g

1-(3-Chloropropyl)-4-methoxybenzene, 95+%, 5g